Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies 2019-04-30
  2. Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography 2014-08-15

Studies

2 studies carry this tag.

Date range

2014 to 2019

Top journals

  • Clinical & experimental ophthalmology 1
  • Parkinsonism & related disorders 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Parkinsonism & related disorders 2019-04-30 Brain scans and imaging

    Parkinson's patients show significant thinning of the inner retinal layers, resembling changes found in glaucoma and other neurodegenerative diseases like Alzheimer's. Study of different cell layers in-vivo is possible by moving from time-to spectral domain OCT.

  2. Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Clinical & experimental ophthalmology 2014-08-15 Brain scans and imaging

    Patients with AD had chorioretinal structural alterations.

All topic tags with their study counts